ALPS Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-79,420
| Closed | -$1.03M | – | 1042 |
|
|
2022
Q1 | $1.03M | Sell |
79,420
-9,439
| -11% | -$122K | 0.01% | 310 |
|
|
2021
Q4 | $1.42M | Sell |
88,859
-4,873
| -5% | -$77.8K | 0.02% | 324 |
|
|
2021
Q3 | $1.51M | Sell |
93,732
-6,038
| -6% | -$97K | 0.01% | 349 |
|
|
2021
Q2 | $1.38M | Sell |
99,770
-31,925
| -24% | -$442K | 0.01% | 370 |
|
|
2021
Q1 | $1.92M | Sell |
131,695
-11,472
| -8% | -$168K | 0.02% | 313 |
|
|
2020
Q4 | $2.49M | Buy |
143,167
+37,755
| +36% | +$656K | 0.03% | 244 |
|
|
2020
Q3 | $1.93M | Sell |
105,412
-6,429
| -6% | -$118K | 0.03% | 240 |
|
|
2020
Q2 | $2M | Sell |
111,841
-32,448
| -22% | -$579K | 0.03% | 237 |
|
|
2020
Q1 | $2.34M | Buy |
144,289
+2,924
| +2% | +$47.4K | 0.04% | 199 |
|
|
2019
Q4 | $2.55M | Buy |
+141,365
| New | +$2.55M | 0.02% | 208 |
|
|
2015
Q4 | – | Sell |
-59,228
| Closed | -$11.9K | – | 685 |
|
|
2015
Q3 | $11.9K | Buy |
59,228
+21,717
| +58% | +$4.35K | 0.01% | 206 |
|
|
2015
Q2 | $1.08M | Buy |
+37,511
| New | +$1.08M | 0.01% | 209 |
|